Overview
Hongbing Ma practices in Chengdu, China. Ma is highly rated in 3 conditions, according to our data. Their top areas of expertise are Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Leukemia, Acute Myelomonocytic Leukemia, and Splenectomy.
Their clinical research consists of co-authoring 44 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)
- Acute Promyelocytic Leukemia
- LeukemiaMa isAdvanced. Learn about Leukemia.
- Experienced
- Acquired HemophiliaMa isExperienced. Learn about Acquired Hemophilia.
- Acute Febrile Neutrophilic Dermatosis
- Acute Lymphoblastic Leukemia (ALL)
- Acute Monoblastic Leukemia (AmoL)
- Acute Myelomonocytic Leukemia
- Autoimmune Hemolytic Anemia